State Of The Art 2024: Asthma

We are delighted to invite you to SOTA Asthma, a premier gathering that aims to cast new light on the ever-evolving landscape of asthma management. Keynote speakers: Michael Wechsler (Denver), Peter Gibson, Christine Jenkins, Michele Goldman, Peter Wark MLSI State of the Art Conference: Asthma July 26th 2024, 08:30 – Read more…

State Of The Art 2023: Sleep

Save the Date: Monash lung and Sleep Institute State of the Art Symposium Sleep Medicine – Fri 28th July 2023 The annual Monash Lung and Sleep Institute annual State of the Art Symposium for 2023 will feature Sleep Medicine, Following on from our highly successful 2017 sleep symposium. The one Read more…

State Of The Art 2022: COPD

COPD is increasingly recognised as a multi-dimensional disorder and SOTA COPD will provide key new information to help clinicians better care for patients. The keynote speaker Prof John Hurst from London has made important contributions to our understanding of COPD exacerbations, preventing acute episodes, optimised management of chronic disease and Read more…

State Of The Art 2022: Asthma

SOTA 2022 has been rescheduled to April 29th 2022. If you have already booked your registration you will be automatically transferred to the new date of April 29th 2022. It is with great pleasure we invite you to attend (FTF again!) our STATE-OF-THE-ART ASTHMA meeting in Melbourne.  A Panel of Read more…

State Of The Art 2020

State Of The Art 2020 The Organising Committee warmly invites you to attend our annual State of the Art conference for 2020 MLSI Annual State of the Art Conference: Sleep Medicine 9th February 2020, RACV City Club: 501 Bourke St, Melbourne VIC 3001 Conference in Pavilion Room on Level 2 Read more…

State of the Art 2019

The Organising Committee warmly invites you to attend our annual State of the Art conference for 2019 MLSI Annual State of the Art ConferenceCOPD: Chronic Obstructive Airway Disease26th July 2019,RACV City Club 501 Bourke St, Melbourne VIC 3000 0800-1730 with drinks and canapés until 1830 Supported GlaxoSmithKline via an unrestricted Read more…